Health Catalyst (HCAT) reported $70.49 million in revenue for the quarter ended June 2026, representing a year-over-year decline of 12.7%. EPS of $0.04 for the same period compares to $0.04 a year ago.

The reported revenue represents a surprise of +2.33% over the Zacks Consensus Estimate of $68.88 million. With the consensus EPS estimate being $0.02, the EPS surprise was +100%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Health Catalyst performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Professional services: $21.69 million versus the two-analyst average estimate of $19.09 million. The reported number represents a year-over-year change of -22.1%.
  • Revenue- Technology: $48.8 million versus the two-analyst average estimate of $50 million. The reported number represents a year-over-year change of -7.7%.
  • Adjusted Gross Profit- Professional Services: $4.86 million versus the two-analyst average estimate of $3.24 million.
  • Adjusted Gross Profit- Technology: $30.98 million compared to the $32.75 million average estimate based on two analysts.

View all Key Company Metrics for Health Catalyst here>>>

Shares of Health Catalyst have returned +8.6% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 

Health Catalyst, Inc. (HCAT): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research